Loading insider details...
Beta
Latest Form 4 (May 11, 2026): Grant/Award of 1,438 CRL shares, $255.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 11, 2026 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/Award | 1,438 | $255.4K |
| Apr 20, 2026 | Kailera Therapeutics, Inc. (KLRA) | Grant/Award | 38,300 | n/a |
| Feb 20, 2026 | Rallybio Corp (RLYB) | Grant/Award | 18,055 | $65.0K |
| May 23, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/Award | 946 | $127.7K |
| May 15, 2025 | Rallybio Corp (RLYB) | Grant/Award | 28,500 | n/a |
| Jan 6, 2025 | Rallybio Corp (RLYB) | Grant/Award | 92,857 | $65.0K |
| Jul 30, 2024 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/Award | 9,963 | n/a |
| May 15, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/Award | 559 | $127.7K |
| Feb 16, 2024 | Rallybio Corp (RLYB) | Grant/Award | 216,000 | n/a |
| Jul 5, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/Award | 95 | n/a |